Dr. Adam Raskin, an interventional cardiologist and medical director at Mercy Health in Cincinnati, dives into the latest advancements in DVT and PE treatments. He emphasizes the need for more randomized trials to refine venous disease guidelines. The discussion highlights innovative thrombectomy systems, the importance of accurate diagnostics, and improved follow-up care to enhance patient outcomes. Raskin also shares insights on future trends in venous interventions, showcasing the evolution of endovascular therapy.